These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14766884)

  • 101. Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method.
    Růzicka F; Holá V; Votava M; Tejkalová R
    Folia Microbiol (Praha); 2007; 52(3):209-14. PubMed ID: 17702457
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2012 Sep; 50(9):2846-56. PubMed ID: 22740712
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro.
    Li Y; Nguyen MH; Cheng S; Schmidt S; Zhong L; Derendorf H; Clancy CJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):369-74. PubMed ID: 18215509
    [TBL] [Abstract][Full Text] [Related]  

  • 104. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.
    Serena C; Ortoneda M; Capilla J; Pastor FJ; Sutton DA; Rinaldi MG; Guarro J
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3161-4. PubMed ID: 14506025
    [TBL] [Abstract][Full Text] [Related]  

  • 105. In vitro anti-Candida activity of lidocaine and nitroglycerin: alone and combined.
    Palmeira-de-Oliveira A; Ramos AR; Gaspar C; Palmeira-de-Oliveira R; Gouveia P; Martinez-de-Oliveira J
    Infect Dis Obstet Gynecol; 2012; 2012():727248. PubMed ID: 22675243
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The fungicidal effectiveness of 2-Chloro-3-hydrazinylquinoxaline, a newly developed quinoxaline derivative, against Candida species.
    Alfadil A; Ibrahem KA; Alrabia MW; Mokhtar JA; Ahmed H
    PLoS One; 2024; 19(5):e0303373. PubMed ID: 38728271
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.
    Ingham CJ; Boonstra S; Levels S; de Lange M; Meis JF; Schneeberger PM
    PLoS One; 2012; 7(3):e33818. PubMed ID: 22439000
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Voriconazole-natural latex dressings for treating infected
    Silva TVD; de Barros NR; Costa-Orlandi CB; Tanaka JL; Moro LG; Pegorin GS; Oliveira KS; Mendes-Gianinni MJ; Fusco-Almeida AM; Herculano RD
    Future Microbiol; 2020 Oct; 15():1439-1452. PubMed ID: 33156698
    [No Abstract]   [Full Text] [Related]  

  • 109. Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.
    Perea S; Pennick GJ; Modak A; Fothergill AW; Sutton DA; Sheehan DJ; Rinaldi MG
    Antimicrob Agents Chemother; 2000 May; 44(5):1209-13. PubMed ID: 10770753
    [TBL] [Abstract][Full Text] [Related]  

  • 110. In vitro Evaluation of Fungal Susceptibility and Inhibition of Virulence by Diosgenin.
    do Socorro Costa M; da Silva ARP; Santos Araújo J; Dos Santos ATL; Fonseca VJA; Gonçalves Alencar G; Moura TF; Gonçalves SA; Filho JMB; Morais-Braga MFB; Andrade-Pinheiro JC; Coutinho HDM
    Chem Biodivers; 2024 Jul; 21(7):e202400444. PubMed ID: 38670923
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories.
    Cendejas-Bueno E; Cuenca-Estrella M; Gomez-Lopez A
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3437-40. PubMed ID: 23650161
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories.
    Halliday CL; Weeks K; Farac K; Alexiou H; Green W; Lopez R; Sarun Y; Weldhagen GF; Hardiman R; Chen SC; Kidd SE
    Pathology; 2022 Dec; 54(7):922-927. PubMed ID: 35931494
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Rapid identification of Candida glabrata with a new commercial test, GLABRATA RTT.
    Freydiere AM; Robert R; Ploton C; Marot-Leblond A; Monerau F; Vandenesch F
    J Clin Microbiol; 2003 Aug; 41(8):3861-3. PubMed ID: 12904403
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Anticandidal activities of terconazole, a broad-spectrum antimycotic.
    Tolman EL; Isaacson DM; Rosenthale ME; McGuire JL; Van Cutsem J; Borgers M; Van den Bossche H
    Antimicrob Agents Chemother; 1986 Jun; 29(6):986-91. PubMed ID: 3729366
    [TBL] [Abstract][Full Text] [Related]  

  • 115. First isolation of Candida oceani from a clinical specimen.
    Chew KL; Octavia S; Teo JWP
    Antonie Van Leeuwenhoek; 2021 Mar; 114(3):337-340. PubMed ID: 33534061
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Comparison of Two Commercial Colorimetric Broth Microdilution Tests for
    Philips S; Van Hoecke F; De Laere E; Vervaeke S; De Smedt R; Boelens J; De Geyter D; Piérard D; Lagrou K
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34062848
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.
    Metin DY; Hilmioglu-Polat S; Samlioglu P; Doganay-Oflazoglu B; Inci R; Tumbay E
    Mycopathologia; 2011 Sep; 172(3):187-99. PubMed ID: 21424603
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Voriconazole in the management of nosocomial invasive fungal infections.
    Pemán J; Salavert M; Cantón E; Jarque I; Romá E; Zaragoza R; Viudes A; Gobernado M
    Ther Clin Risk Manag; 2006 Jun; 2(2):129-58. PubMed ID: 18360588
    [TBL] [Abstract][Full Text] [Related]  

  • 119. In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.
    Linares MJ; Solís F; Casal M
    J Clin Microbiol; 2005 May; 43(5):2520-2. PubMed ID: 15872301
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.
    Linares MJ; Charriel G; Solís F; Rodriguez F; Ibarra A; Casal M
    J Clin Microbiol; 2005 Jan; 43(1):250-3. PubMed ID: 15634979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.